Enhancement of in vivo hypoglycemic effect of gliclazide by developing self-microemulsifying pellet dosage form
Abstract Background The present research was aimed to develop a self-microemulsifying drug delivery system (SMEDDS) pellet to increase the dissolution rate Storage Accessories and in vivo hypoglycemic effect of gliclazide.Gliclazide belongs to BCS class 2 and it exhibits dissolution rate-limited absorption.Thus, dissolution enhancement of gliclazid